Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic

Area of Science:

• Rheumatology
• Clinical Immunology
• Internal Medicine

Background:

• Distinguishing early rheumatoid arthritis (RA) from self-limiting polyarthritis is vital due to treatment risks.
• Conventional clinical and laboratory variables are used to predict disease persistence.

Purpose of the Study:

• To evaluate the predictive ability of early clinical and laboratory variables for distinguishing persistent synovitis from self-limiting synovitis in early RA.
• To identify key variables that aid in differentiating these conditions at initial presentation.

Main Methods:

• A cohort of 112 patients with up to 6 months of joint symptoms was studied.
• 65 patients with symmetrical peripheral polyarthritis were followed for 1 year, categorized into self-limiting synovitis (SLS) and persistent synovitis (PS).
• Univariate and multivariate analyses were performed on clinical and laboratory data.

Main Results:

• Significant overlap was observed between SLS and PS, making early clinical discrimination challenging.
• The RA latex test was the most powerful predictor but explained only 45% of outcome variability.
• A positive RA latex test combined with an erythrocyte sedimentation rate (ESR) > 30 mm/h yielded a relative risk of 4.33 for PS (94% specificity, 69% sensitivity).

Conclusions:

• Early self-limiting synovitis can be indistinguishable from early rheumatoid arthritis.
• Rheumatoid arthritis may present in both a traditional persistent form and a less recognized abortive form.
• Specific combinations of markers, like RA latex and ESR, can improve the prediction of persistent disease.